TIFFANY MIN: Open Payments
NPI 1699497719 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 10 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $492 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 4 | $194 |
| ABBVIE INC. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
Products named: ZENPEP, VOWST, RINVOQ, ENTYVIO, VYALEV.
Industry payments across NY — which companies pay providers there.
